Healing Over Management
Our Philosophy
We reject the high-cost paradigm of modern pharmaceuticals, which often prioritizes long-term disease management over true recovery. Instead of relying on escalating dosages and lifelong dependency, our philosophy centers on addressing the biological drivers of disease. By utilizing synergistic, low-dose drug repurposing, we seek to restore systemic function and support the body’s innate capacity to heal, offering a potentially safer, more cost-effective therapeutic approach.
Learn More
Making the Unaffordable, Affordable
Our optimized combination strategies reduce development and manufacturing costs — so more patients get the care they need, sooner.
Affordability
We aim to reduce the annual cost of therapy from hundreds of thousands of dollars to more sustainable and accessible levels.
Through the use of repurposed, well-characterized medications and optimized combination strategies, we significantly lower development, manufacturing, and treatment costs. This approach expands access to care, eases financial strain on patients and healthcare systems, and enables broader adoption across diverse populations and healthcare settings.
Toxicity Reduction
Our UMD approach allows for lower dosages of functional medications, minimizing side effects and supporting improved clinical outcomes.
By targeting disease mechanisms across upstream, midstream, and downstream pathways, we reduce the need for aggressive single-agent dosing. This results in improved tolerability, reduced cumulative toxicity, and better long-term outcomes, while preserving quality of life throughout treatment.
Treatment Shouldn't Feel Worse Than the Disease
By attacking upstream, midstream, and downstream pathways simultaneously, we eliminate the need for aggressive single-agent dosing.
Built for the System. Designed for the Patient.
Our model supports national priorities — lower drug costs, value-based care, and sustainable healthcare spending at scale.
National Alignment
Our approach is aligned with broader healthcare priorities to lower prescription drug prices and reduce the national healthcare burden.
By prioritizing cost efficiency, safety, and durable clinical benefit, our model aligns with public health efforts focused on value-based care, improved patient outcomes, and sustainable healthcare spending at a national level.